Irish Independent – Open Orphan subsidiary starts testing drug for treating Covid-19 April 24, 2020 – Posted in: Open Orphan (ORPH)

by Ellie Donnelly A subsidiary of Open Orphan has started testing a drug that could potentially treat Covid-19. Open Orphan is a Europe- focused pharma services company specialising in rare disease and so-called orphan drugs. The tests are being carried out by its London-based subsidiary Hvivo on behalf of its client Nearmedic International. The drug being tested has both potential anti-viral and anti-inflammatory activity, and therefore could reduce both virus infectivity and disease severity respectively,…

Continue reading